Julian Moran, BSc
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
Rationale and design of the PIONEER PLUS study evaluating high dose oral GLP-1 receptor agonist therapy for the treatment of type 2 diabetes
Childhood Trauma is Associated with Cognitive Functioning in Adult Affectively Stable Patients with Bipolar Disorder
Commensal modulation of Clostridioides difficile infection in vivo
Aortic stenosis analysis using a novel fully automatic AI powered toolbox
PAX8-directed nanotherapeutics for high-grade serous ovarian cancer
